Literature DB >> 27207430

Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance.

Karin M Hoffmeister1, Hervé Falet2.   

Abstract

The daily production of billions of platelets must be regulated to avoid spontaneous bleeding or arterial occlusion and organ damage. Complex mechanisms control platelet production and clearance in physiological and pathological conditions. This review will focus on the mechanisms of platelet senescence with specific emphasis on the role of post-translational modifications in platelet life-span and thrombopoietin production downstream of the hepatic Ashwell-Morrell receptor.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ashwell Morell Receptor; JAK2; STAT3; glycans; platelet clearance; thrombopoietin

Mesh：

Substances：

Year:  2016        PMID： 27207430      PMCID： PMC5399515          DOI： 10.1016/S0049-3848(16)30370-X

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


  62 in total

1.  Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin.

Authors:  M Ballmaier; H Schulze; G Strauss; K Cherkaoui; N Wittner; S Lynen; S Wolters; J Bogenberger; K Welte
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Experimental modification of platelet survival.

Authors:  H J Reimers; J Greenberg; J P Cazenave; M A Packham; J F Mustard
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

Review 3.  Myeloproliferative disorders.

Authors:  Ross L Levine; D Gary Gilliland
Journal:  Blood       Date:  2008-09-15       Impact factor: 22.113

Review 4.  Thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  Semin Hematol       Date:  2014-10-31       Impact factor: 3.851

Review 5.  Interleukin-6 signalling: more than Jaks and STATs.

Authors:  René Eulenfeld; Anna Dittrich; Christina Khouri; Pia J Müller; Barbara Mütze; Alexandra Wolf; Fred Schaper
Journal:  Eur J Cell Biol       Date:  2011-12-03       Impact factor: 4.492

6.  Platelet-derived serotonin mediates liver regeneration.

Authors:  Mickael Lesurtel; Rolf Graf; Boris Aleil; Diego J Walther; Yinghua Tian; Wolfram Jochum; Christian Gachet; Michael Bader; Pierre-Alain Clavien
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

7.  An experience of oseltamivir phosphate (tamiflu™) in a pediatric patient with chronic idiopathic thrombocytopenic purpura: a case report.

Authors:  Bulent Alioglu; Aysin Tasar; Cinar Ozen; Beray Selver; Yildiz Dallar
Journal:  Pathophysiol Haemost Thromb       Date:  2010-11-09

8.  Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor.

Authors:  Prabhjit K Grewal; Peter V Aziz; Satoshi Uchiyama; Gabriel R Rubio; Ricardo D Lardone; Dzung Le; Nissi M Varki; Victor Nizet; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

9.  The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.

Authors:  Renata Grozovsky; Antonija Jurak Begonja; Kaifeng Liu; Gary Visner; John H Hartwig; Hervé Falet; Karin M Hoffmeister
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

Review 10.  Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia.

Authors:  David J Kuter
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739
View more
  20 in total

1.  Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets.

Authors:  M Edward Quach; Matthew A Dragovich; Wenchun Chen; Anum K Syed; Wenpeng Cao; Xin Liang; Wei Deng; Simon F De Meyer; Guangheng Zhu; Jun Peng; Heyu Ni; Carolyn M Bennett; Ming Hou; Jerry Ware; Hans Deckmyn; X Frank Zhang; Renhao Li
Journal:  Blood       Date:  2017-12-04       Impact factor: 22.113

Review 2.  Clinical updates in adult immune thrombocytopenia.

Authors:  Michele P Lambert; Terry B Gernsheimer
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

Review 3.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

4.  Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia.

Authors:  Josh Sun; Satoshi Uchiyama; Joshua Olson; Yosuke Morodomi; Ingrid Cornax; Nao Ando; Yohei Kohno; May M T Kyaw; Bernice Aguilar; Nina M Haste; Sachiko Kanaji; Taisuke Kanaji; Warren E Rose; George Sakoulas; Jamey D Marth; Victor Nizet
Journal:  Sci Transl Med       Date:  2021-03-24       Impact factor: 19.319

Review 5.  Quality Assessment of Established and Emerging Blood Components for Transfusion.

Authors:  Jason P Acker; Denese C Marks; William P Sheffield
Journal:  J Blood Transfus       Date:  2016-12-14

6.  Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production.

Authors:  Jooyoung Cho; Hyunkyung Kim; Jaewoo Song; June-Won Cheong; Jeong Won Shin; Woo Ick Yang; Hyun Ok Kim
Journal:  J Transl Med       Date:  2018-07-18       Impact factor: 5.531

7.  A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.

Authors:  Maaike Rijkers; Anno Saris; Sebastiaan Heidt; Arend Mulder; Leendert Porcelijn; Frans H J Claas; Ruben Bierings; Frank W G Leebeek; A J Gerard Jansen; Gestur Vidarsson; Jan Voorberg; Masja de Haas
Journal:  Haematologica       Date:  2018-06-01       Impact factor: 9.941

Review 8.  Regulation of Platelet Production and Life Span: Role of Bcl-xL and Potential Implications for Human Platelet Diseases.

Authors:  Emma C Josefsson; William Vainchenker; Chloe James
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

9.  Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling.

Authors:  Szu-Yuan Wu; Wan-Yu Yang; Chun-Chia Cheng; Kuan-Hao Lin; Bonifasius Putera Sampurna; Suat-Ming Chan; Chiou-Hwa Yuh
Journal:  Clin Transl Med       Date:  2017-07-28

10.  Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis.

Authors:  Chun-Chia Cheng; Wan-Yu Yang; Ming-Chen Hsiao; Kuan-Hao Lin; Hao-Wei Lee; Chiou-Hwa Yuh
Journal:  Biomolecules       Date:  2020-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.